BI 767551

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 767551, covering 2021-11-08 to 2022-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 [Phase 2, Phase 3]